Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma

Clinical trial NCT07144254 · RECRUITING

Trial details

NCT number: NCT07144254
Sponsor: Emory University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Osteosarcoma Recurrent Osteosarcoma in Children Relapsed Osteosarcoma Refractory Osteosarcoma

Start date: 2026-01-22
Primary completion: 2028-05-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.